Table 1

Characteristics of the patients and their tumours

Patient NoAge/sexSymptoms/ KPSHistology IPDGFRα positive cells I (%)Histology IIPDGFRα positive cells II (%)
A-2/3, astrocytoma, WHO grade 2/3; C, cognitive dysfunction; Ep, epileptic seizure or epilepsy; F, female; H, headache; KPS, Karnofsky performance status; M, male; OA-2/3, oligoastrocytoma, WHO grade 2/3; OS, other symptoms; P, paresis; I, first operation/biopsy; II, second operation/biopsy.
133/FEp,C/90A-240
229/FEp,OS/90A-233A-240
334/FEp,H/90A-229OA-260
431/MEp/90A-250OA-327
524/MOS/90A-235
659/MEp/90A-254
735/MEp/90A-262A-233
863/MEp,C/80A-253
930/MEp/90A-231
1062/MP/40A-245
1157/MEp,H/90A-225
1279/FEp,P/70A-25
1349/MEp, C/90A-229
1436/MEp/90A-240
1533/MEp/90A-233
1669/MEp,OS/90A-210
1748/MEp,P/70OA-250
1841/MEp,H,C/90OA-251
1940/MEp,C/80A-238
2039/FEp/90A-243
2146/MEp/90A-234A-30
2239/MEp/90OA-246A-320
2329/FEp,H/90A-240A-319
2440/MC,OS/60A-261
2567/FEp,C/90OA-247
2635/MEp/90A-231
2748/MEp/90A-270
2831/MEp,H/90A-234
2920/MH,OS/90A-237
3030/MEp/90A-247
3151/FEp,H/90A-259
3236/MEp/90A-229
3347/MEp/90OA-265
3436/FEp,H/90A-247
3540/MEp,C/80A-255
3647/MEp,H/90OA-229
3753/MH,C,OS/70A-234
3841/MEp/90A-248
3938/MEp/90A-253
4052/MEp,C/90OA-256